期刊文献+

巨大肝癌的外科治疗:附146例报告 被引量:7

Surgical treatment for giant primary liver cancer:a report of 146 cases
下载PDF
导出
摘要 目的 探讨巨大肝癌外科治疗的效果。方法 回顾性分析近 11年间收治的 14 6例原发性巨大肝癌的外科治疗情况。 14 6例均经手术治疗 ,其中行不规则肝切除 99例 ,半肝切除 2 8例 ,右三叶切除 4例 ,包括术前行TACE后获得二期切除 19例 ;6例同时行门静脉切开取栓术。另 15例仅行活检 +DDS ,术中行DDS治疗者 10 5例。结果 手术并发症发生率 10 .3 % ,术后 1个月内病死率1.4% ,术后 1,3 ,5年和 10年的生存率分别为 5 6.6% ,3 0 .2 % ,14 .4%和 2 .1%。结论 巨大肝癌仍以手术切除为主 ,疗效满意。结合TACE、门静脉取栓和DDS能提高患者的远期生存率。 Objective To investigate the effect of surgical treatment for giant primary liver cancer.Methods One hundred and forty-six cases of giant primary liver cancer received surgical treatment in recent 11 years ware analyzed retrospectively. Of them, 99 cases underwent irregular hepatectomy ,28 hemihepatectomy and 4 right hepatic trisegmentectomy .Including 19 cases received secondary resection after preoperative TACE, meanwhile 6 cases were underwent portal venous cancer thrombus extraction, 15 cases received biopsies and DDS only, Interoprative DDS were performed in 105 cases. Result The postoperative complications was 10.3 %, the postoperative mortality was 1.4%.The 1-,3-,5- and 10year survival rates were 56.6 %, 30.2% ,14.4% and 2.1% respectively. Conclusions The main treatment of giant liver cancer is hepatcctomy.Combination with TACE,portal thrombus extraction and DDS can improve the long-term survival.
出处 《中国普通外科杂志》 CAS CSCD 2004年第3期164-166,共3页 China Journal of General Surgery
关键词 肝肿瘤/外科学 肝切除术 LIVER NEOPLASMS/surg HEPATECTOMY
  • 相关文献

参考文献5

二级参考文献25

  • 1彭淑牖,蔡秀军,李君达,范明敏,束美宝,陈通.不同肝脏功能状况下人肝热缺血时限研究[J].临床外科杂志,1993,1(1):20-21. 被引量:37
  • 2彭淑牖,江献川,李君达,蔡秀军,彭承宏,苏英.刮吸法断肝术临床应用报告[J].实用外科杂志,1993,13(1):17-19. 被引量:112
  • 3何生,吴钧,周翔平.肝尾叶切除[J].华西医科大学学报,1994,25(2):200-202. 被引量:5
  • 4彭淑牖,江献川,彭承宏,蔡秀军,牟一平,陆才德,苏英,郑放.肝尾叶单独或联合切除[J].实用肿瘤杂志,1995,10(3):143-145. 被引量:16
  • 5彭淑牖,江献川,牟一平,彭承宏,蔡秀军.尾叶原发性肝癌的手术切除(附12例报告)[J].中国实用外科杂志,1997,17(1):19-21. 被引量:10
  • 6Akanuma M,Yoshida H, Okamoto M, et al. Risk factors for esophageal variceal bleeding in patients with hepatocellur carcinoma [ J ]. Hepatogastroenterology,2002,49(46) : 1039 - 1044.
  • 7Arii S, Okamoto E, Imamura M. Registries in Japan:current status of hepatocellur carcinoma in Japan [ J ]. Semin Surg Oncol, 1996,12 (3) :204 -211.
  • 8Poon RT, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection of hepatocellur carcinoma long term results of treatment and prognostic factors [ J ]. Ann Surg, 1999,229 (2) :216 - 222.
  • 9Koh T,Taniguchi H,Katoh H, et al. Are both PIVKA-Ⅱ and α-Fetoprotein necessary in follow-up management after hepatic resection for hepatocellur carcinoma? [ J ]. Hepatogastroenterology, 2002,49 ( 48 ) :1615 -1618.
  • 10Bismuth H. Surgical anatomy and anatomical surgery of the liver[J]. World J Surg, 1982,6(1):3-9.

共引文献74

同被引文献43

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部